Post-cycle therapy for performance and image enhancing drug users: A qualitative investigation

Adair, 2015, Steroids, male body image, and the intimate self Bhasin, 1996, The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men, New England Journal of Medicine, 335, 1, 10.1056/NEJM199607043350101 Bhasin, 2001, Testosterone dose-response relationships in healthy young men, American Journal of Physiology Endocrinology and Metabolism, 281, 1172, 10.1152/ajpendo.2001.281.6.E1172 Cohen, 2006, A league of their own: Demographics, motivations and patterns of use of 1955 male adult non-medical anabolic steroid users in the United States, Journal of the International Society of Sports Nutrition, 4 Dennington, 2008 Denzin, 2011 Dunn, 2016, Do performance and image enhancing drug users in regional Queensland experience difficulty accessing health services?, Drug and Alcohol Review, 35, 377, 10.1111/dar.12363 Griffiths, S., & Murray, S. B.. (in press). Muscle Dysmorphia: Clinical Presentation and Treatment: Strategies. In L. K. Anderson, S. B. Murray, & W. H. Kaye (Eds.), Handbook of Complex and Atypical Eating Disorders. Griffiths, 2016, Anabolic steroids: Lots of muscle in the short-term, potentially devastating health consequences in the long-term, Drug and Alcohol Review, 35, 375, 10.1111/dar.12433 Hildebrandt, 2010, Body image disturbance in 1000 male appearance and performance enhancing drug users, Journal of Psychiatric Research, 44, 841, 10.1016/j.jpsychires.2010.01.001 Hildebrandt, 2011, Development and validation of the appearance and performance enhancing drug use schedule, Addictive Behaviors, 36, 949, 10.1016/j.addbeh.2011.05.002 Ip, 2011, The anabolic 500 survey: Characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training, Pharmacotherapy, 31, 757, 10.1592/phco.31.8.757 Iversen, 2015 Kanayama, 2008, Long term psychiatric and medical consequences of anabolic androgenic steroid abuse: A looming public health concern, Drug and Alcohol Dependence, 98, 1, 10.1016/j.drugalcdep.2008.05.004 Kanayama, 2010, Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications, Drug and Alcohol Dependence, 109, 6, 10.1016/j.drugalcdep.2010.01.011 Karila, 2005, Acute and chronic cognitive disorders caused by cannabis use, Revue Du Praticien, 55, 23 Marks, 2004 Miles, 1994 Mosley, 2009, Bigorexia: Bodybuilding and muscle dysmorphia, European Eating Disorders Review, 17, 191, 10.1002/erv.897 Murray, 2016, Go big or go home: A thematic content analysis of pro-muscularity websites, Body Image, 16, 17, 10.1016/j.bodyim.2015.10.002 Murray, 2016, Anabolic steroid use and body image psychopathology in men: Delineating between appearance-versus performance-driven motivations, Drug and Alcohol Dependence, 165, 198, 10.1016/j.drugalcdep.2016.06.008 Olivardia, 2000, Muscle dysmorphia in male weightlifters: A case-control study, American Journal of Psychiatry, 157, 1291, 10.1176/appi.ajp.157.8.1291 Petersson, 2006, Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids, Drug and Alcohol Dependence, 81, 241, 10.1016/j.drugalcdep.2005.07.003 Pope, 2005, Anabolic-androgenic steroid abuse, 1318 Pope, 2004, Anabolic steroid users’ attitudes towards physicians, Addiction, 99, 1189, 10.1111/j.1360-0443.2004.00781.x Pope, 2005, Clinical features of muscle dysmorphia among males with body dysmorphic disorder, Body Image, 2, 395, 10.1016/j.bodyim.2005.09.001 Reyes-Fuentes, 1993, Neuroendocrine physiology of the normal male gonadal axis, Endocrinology and Metabolism Clinics of North America, 22, 93, 10.1016/S0889-8529(18)30182-8 Smith, 2012, Body conceptions and virtual ethnopharmacology in an online bodybuilding community, Performance Enhancement & Health, 1, 35, 10.1016/j.peh.2012.04.001